---
title: "Hong Kong stock movement: TOUYUN BIOTECH rose 12.87%, but the biotechnology sector has scarce positive news, and continuous capital outflows have raised market concerns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273641611.md"
description: "TOUYUN BIOTECH rose 12.87%; Qiming Oriental Holdings fell 7.09%, with a transaction volume of HKD 814,900; Jiayao Holdings fell 0.41%, with a transaction volume of HKD 297,700; Zhongbao New Materials had a transaction volume of HKD 137,500; Sunshine Paper's market value reached HKD 1.331 billion"
datetime: "2026-01-26T03:11:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273641611.md)
  - [en](https://longbridge.com/en/news/273641611.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273641611.md)
---

# Hong Kong stock movement: TOUYUN BIOTECH rose 12.87%, but the biotechnology sector has scarce positive news, and continuous capital outflows have raised market concerns

**Hong Kong Stock Movement**

TOUYUN BIOTECH rose 12.87%. Based on recent news,

1.  On January 23, TOUYUN BIOTECH encountered a significant drop during the trading session, with a substantial increase in trading volume throughout the day, leading to a decline in risk appetite to a recent low. The market showed strong risk aversion, making it difficult for major players to see clear signs of replenishment, with a wait-and-see sentiment dominating trading, and funds attempting to buy on the left side struggling to reverse the overall pressure.
    
2.  Regarding the company's recent focus—Rhein Algae product division, from an industry perspective, there has been a scarcity of positive news for the biotechnology sector at the beginning of the year, with continuous outflows of funds from the main line of the sector. Companies with high R&D investments frequently report performance losses, leading to a cooling of market enthusiasm. Ongoing tightening of overseas regulations and delays in drug review and approval have resulted in a lack of marginal improvement momentum for the overall sector.
    
3.  TOUYUN BIOTECH's stock price has consecutively fallen below important moving averages in recent trading days, with the MACD losing the zero axis, and all short-term moving averages breaking down, indicating a continuous release of short-term bearish energy, with very weak rebound momentum. Technically, the key support area is around 0.20; if it is breached again, bearish pressure may further intensify. Although trading volume increased during the session, there was no significant reversal in the decline, with low participation from major players and a lack of confidence.
    

**Stocks with High Trading Volume in the Industry**

Qiming Oriental Holdings fell 7.09%, with a trading volume of HKD 814,900, and no significant news recently. The trading is active, with clear fund flows, and considering the sector and industry trends, this stock shows significant volatility, with specific reasons needing further observation.

Jiayao Holdings fell 0.41%, with a trading volume of HKD 297,700, and no significant news recently. The trading is active, with clear fund flows, and considering the sector and industry trends, this stock shows significant volatility, with specific reasons needing further observation.

Zhongbao New Materials had a trading volume of HKD 137,500, and no significant news recently. The trading is active, with clear fund flows, and considering the sector and industry trends, this stock shows significant volatility, with specific reasons needing further observation.

**Stocks with High Market Capitalization in the Industry**

Sun Paper Holdings has a market capitalization of HKD 1.331 billion, with no significant news recently. The trading is active, with clear fund flows, and considering the sector and industry trends, this stock shows significant volatility, with specific reasons needing further observation

### Related Stocks

- [01332.HK](https://longbridge.com/en/quote/01332.HK.md)

## Related News & Research

- [Touyun Biotech Details Financing and Asset Moves to Address Audit Qualification and Support Growth](https://longbridge.com/en/news/271200522.md)
- [Stocks in Play: Oncolytics Biotech Inc](https://longbridge.com/en/news/284230718.md)
- [Precise Biometrics Shareholders Approve Merger Steps With Fingerprint Cards](https://longbridge.com/en/news/284731647.md)
- [Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations | TRIB Stock News](https://longbridge.com/en/news/284903266.md)
- [Seaport Therapeutics raises about $255 million in upsized IPO](https://longbridge.com/en/news/284862558.md)